Form 8K eXoZymes Inc For: 10 April
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
eXoZymes Inc (EXOZ)
Track the eXoZymes share price today and view real-time EXOZ share price data, including charts, technicals, and key financials. View the EXOZ premarket stock price ahead of the market session or assess the after hours quote. Explore EXOZ stock price movements, trading volume, and market activity across the NASDAQ exchange.
What Is the eXoZymes Stock Price Today?
The eXoZymes stock price today is 10.14.
What Is the Stock Symbol for eXoZymes?
The stock symbol for eXoZymes is ""EXOZ.""
What Stock Exchange Does eXoZymes Trade On?
eXoZymes is listed and trades on the NASDAQ stock exchange.
Is eXoZymes a Good Stock to Buy?
Determining whether eXoZymes or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EXOZ quote. (ISIN: US4618741098)
What Is the eXoZymes Stock Price Today?
The eXoZymes stock price today is 10.14.
What Is the Stock Symbol for eXoZymes?
The stock symbol for eXoZymes is ""EXOZ.""
What Stock Exchange Does eXoZymes Trade On?
eXoZymes is listed and trades on the NASDAQ stock exchange.
Is eXoZymes a Good Stock to Buy?
Determining whether eXoZymes or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EXOZ quote. (ISIN: US4618741098)
NASDAQ
Currency in USD
10.14
-0.36(-3.43%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.14
10.14
52 wk Range
7.08
18.40
EXOZ is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.1410.14
52 wk Range
7.0818.40
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EXOZ Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Liquid assets exceed short term obligations
- eXoZymes CCO discusses NCTx spinout on podcast
- Investing.com
- Form 8K eXoZymes Inc For: 31 March
- Investing.com
- Form 8K eXoZymes Inc For: 10 April
- Investing.com
- eXoZymes CCO discusses NCTx spinout on podcast
- Investing.com
- Form 424B5 eXoZymes Inc For: 9 April
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
eXoZymes Inc Earnings Call Summary for Q4/2025
- eXoZymes reported $9.16M net loss for 2025; operating expenses rose 63.6% YoY to $9.72M amid strategic pivot to product development.
- Cash position of $3.04M provides runway through mid-Q2 2026; financing round with terms expected by April 2026 to support operations.
- Company achieved pilot-scale production of flagship NCT product with 99%+ purity; commercial production targeted for 2027.
- Strategic shift from partnerships to internal asset development aims to maximize shareholder value through full product commercialization.
- Pre-revenue biotech focuses on NCT metabolic health program with human studies planned; regulatory timelines remain key execution risk.
Last Updated: 01/04/2026, 09:44 am
Read Full TranscriptCompare EXOZ to Peers and Sector
Metrics to compare | EXOZ | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEXOZPeersSector | |
|---|---|---|---|---|
P/E Ratio | −9.4x | −4.3x | −0.5x | |
PEG Ratio | 0.42 | −0.09 | 0.00 | |
Price/Book | 25.3x | 5.5x | 2.6x | |
Price / LTM Sales | - | 9.5x | 3.2x | |
Upside (Analyst Target) | - | 70.9% | 47.4% | |
Fair Value Upside | Unlock | −1.2% | 7.7% | Unlock |
Earnings
Latest Release
30/03/2026
EPS / Forecast
-0.32 / --
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the eXoZymes (EXOZ) Stock Price Today?
The eXoZymes stock price today is 10.14 USD.
What Stock Exchange Does eXoZymes Trade On?
eXoZymes is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for eXoZymes?
The stock symbol for eXoZymes is "EXOZ."
What Is the eXoZymes Market Cap?
As of today, eXoZymes market cap is 87.42M USD.
What Is eXoZymes's Earnings Per Share (TTM)?
The eXoZymes EPS (TTM) is -1.09.
From a Technical Analysis Perspective, Is EXOZ a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has eXoZymes Stock Split?
eXoZymes has split 0 times.
How Many Employees Does eXoZymes Have?
eXoZymes has 32 employees.
What is the current trading status of eXoZymes (EXOZ)?
As of 25/04/2026, eXoZymes (EXOZ) is trading at a price of 10.14 USD, with a previous close of 10.31 USD. The stock has fluctuated within a day range of 10.14 USD to 10.14 USD, while its 52-week range spans from 7.08 USD to 18.40 USD.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.